Affordable Access

Publisher Website

Obstructive sleep apnea in children: a critical update

Nature and Science of Sleep
Dove Medical Press
Publication Date
DOI: 10.2147/nss.s51907
  • Review
  • Biology
  • Medicine


Obstructive sleep apnea (OSA) in children is a highly prevalent disorder caused by a conglomeration of complex pathophysiological processes, leading to recurrent upper airway dysfunction during sleep. The clinical relevance of OSA resides in its association with significant morbidities that affect the cardiovascular, neurocognitive, and metabolic systems. The American Academy of Pediatrics recently reiterated its recommendations that children with symptoms and signs suggestive of OSA should be investigated with polysomnography (PSG), and treated accordingly. However, treatment decisions should not only be guided by PSG results, but should also integrate the magnitude of symptoms and the presence or absence of risk factors and signs of OSA morbidity. The first-line therapy in children with adenotonsillar hypertrophy is adenotonsillectomy, although there is increasing evidence that medical therapy, in the form of intranasal steroids or montelukast, may be considered in mild OSA. In this review, we delineate the major concepts regarding the pathophysiology of OSA, its morbidity, diagnosis, and treatment.

There are no comments yet on this publication. Be the first to share your thoughts.


Seen <100 times

More articles like this

Obstructive sleep apnea in children: an update.

on Pediatric clinics of North Ame... April 2003

Update in obstructive sleep apnea syndrome in chil...

on Brazilian Journal of Otorhinol... 2005
More articles like this..